Pharma Blog
Navigating Bioequivalence Study Guidelines Across Global Regulatory Bodies
When conducting bioequivalence (BE) or bioavailability (BA) studies for regulatory approval, guidelines from different regulatory bodies must be adhered to. Here’s a summary of the key considerations and variations across major regulatory agencies Regulatory Guidelines Comparison USFDA Special Cases: Study Design: EMA Acceptance Range: Study Design: WHO Study Design: MHRA ... Read More
Understanding Patent Length and Generic Competition in Pharmaceuticals
Hello everyone! I’ve been preparing to share more insights on pharmaceutical regulations in the future, and today I’ve learned about patents, FDA approvals, and how generics enter the market. How Patent Protection Works Patent Duration FDA Approval Time What Happens After the Patent Expires? Generic Drug Applications Market Exclusivity for ... Read More
Pharmacokinetics of Naproxen
In linear pharmacokinetics (PK), when we increase the dose (D) of the drug, its level in our body or systemic exposure (AUC) increases proportionally (red curve on left graph). What is our inference? This implies that both oral bioavailability (F) and clearance (CL) are constant such that dose (D) and ... Read More
Classification of Antibiotics
Inhibitors of Cell Wall Synthesis These antibiotics target the bacterial cell wall, leading to lysis and death. Beta-lactams: Interfere with peptidoglycan synthesis by inhibiting penicillin-binding proteins (PBPs).Examples: Glycopeptides: Bind to peptidoglycan precursors, preventing cross-linking.Examples: Vancomycin, Teicoplanin. Others: Bacitracin (used topically). Inhibitors of Protein Synthesis These antibiotics target bacterial ribosomes, disrupting ... Read More
Comprehensive List of Pharmaceutical Guidelines
Self Inspection & Batch Review Risk Management Deviation Handling Change Control Out of Specification (OOS) Corrective and Preventive Action (CAPA) Process Validation Cleaning Validation Data Integrity Stability Studies GMP Pharmaceutical Quality System Pharmaceutical Development Good Storage and Distribution Practices (GSDP) Electronic documents and records Read also:
Importance of Drug Optimization
Let’s talk about the importance of “Drug optimization” which is a crucial concept in medicinal chemistry and drug design. It refers to the strategy of replacing one chemical group with another that has similar biological activity but different pharmacokinetic properties. For example, consider two NSAIDs available in the market which ... Read More
Citric Acid Cycle: A Journey Into Cellular Metabolism
The Citric Acid Cycle, also known as the Krebs Cycle or TCA Cycle, is foundational to understanding how our cells produce energy. This intricate pathway converts nutrients into usable energy, driving every cellular function. Let’s delve into the details of this essential cycle and its broader implications. The Central Role ... Read More
ESC Key Notes on Obesity and Cardiovascular Disease
European Society of Cardiology (ESC) Clinical Consensus Statement on Obesity and Cardiovascular Disease Read also: Read also: Dr. Suzan Gharaibeh
Impurity Specification Across Different Regulatory Bodies
Impurities in pharmaceutical products play a critical role in ensuring drug quality, safety, and efficacy. Regulatory bodies such as the USFDA, EMA, PMDA, and others have specific guidelines for identifying, quantifying, and controlling impurities. Types of Impurities Key Guidelines for Impurity Control USFDA EMA PMDA (Japan) WHO Indian Pharmacopeia Differences ... Read More
Justification for Control of Elemental Impurities in Formulation
Introduction Definition: Elemental impurities are trace levels of metals that can be introduced into drug products from raw materials, manufacturing processes, or container closure systems. Regulatory requirement: ICH Q3D and relevant pharmacopeial guidelines (USP <232>, <233>) specify acceptable limits for elemental impurities to ensure patient safety. Identification of Potential Sources ... Read More
Trend Analysis for Elemental Impurities
Trend analysis for elemental impurities is not explicitly required by guidelines like ICH Q3D . However, certain aspects of stability trends and variability need to be considered to ensure compliance and accurate reporting. Stability Trends for Elemental Impurities In most cases, if no such risk is identified, monitoring for trends ... Read More